Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — MDXG

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	120.79	135.84	159.77	166.12	142.08	118.87	106.43	104.42	88.80	69.04	48.49	82.00	81.16	68.65	61.22	65.95	73.22	72.50	75.68	87.08
Accounts Receivable	37.27	41.30	46.03	75.71	78.19	69.23	62.29	55.83	54.03	52.80	57.02	53.87	49.01	48.96	44.69	43.08	40.83	37.66	37.67	40.35
Inventory	22.09	20.93	26.23	25.34	26.50	24.89	24.07	23.81	24.25	25.06	24.45	21.02	19.07	16.82	14.66	13.18	13.98	13.38	13.17	11.39
Total Current Assets	187.23	205.37	240.33	277.47	254.10	220.88	200.11	191.89	172.14	154.02	138.85	164.26	154.50	141.22	131.70	134.20	136.04	131.01	135.91	148.52
Property, Plant & Equipment	4.71	4.91	4.76	4.71	5.00	5.39	5.77	5.94	6.45	6.82	7.34	6.97	7.09	7.26	7.56	7.86	7.91	8.33	8.76	9.16
Goodwill	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.44	19.98	19.98	19.98	19.98	19.98	19.98
Intangible Assets	10.05	10.99	12.03	13.12	10.06	10.95	9.82	10.33	9.70	10.05	10.55	3.17	3.29	3.48	3.66	3.81	2.88	3.04	3.08	3.17
Total Non-current Assets*	77.32	75.63	68.35	65.18	64.89	70.23	70.31	72.03	71.75	76.17	82.83	74.79	34.52	35.16	36.46	37.23	36.76	37.66	38.54	39.41
Total Assets	264.55	281.00	308.68	342.65	318.99	291.11	270.42	263.92	243.89	230.18	221.68	239.05	189.02	176.38	168.16	171.43	172.80	168.67	174.44	187.93
Accounts Payable	11.83	8.29	11.46	14.53	11.42	8.50	8.87	7.41	6.92	7.60	9.70	9.05	9.17	8.15	7.82	8.85	8.82	8.07	8.12	7.39
Total Current Liabilities	43.03	38.50	44.55	64.27	57.68	50.29	42.62	45.60	41.94	40.01	42.22	46.01	43.63	44.46	40.87	43.56	45.86	37.14	36.59	42.36
Long-term Debt	0.00	15.71	16.09	18.00	16.84	17.21	17.53	19.00	18.02	18.25	18.45	50.00	48.97	48.84	48.71	50.00	48.48	48.36	48.24	50.00
Total Non-current Liabilities*	10.44	26.50	21.19	21.84	22.36	24.20	25.03	25.21	20.94	22.13	23.73	50.32	51.57	52.09	52.74	53.37	53.97	52.64	52.79	53.00
Total Liabilities	53.47	65.00	65.74	86.11	80.04	74.49	67.64	70.81	62.88	62.14	65.95	96.33	95.20	96.55	93.61	96.92	99.82	89.78	89.38	95.35
Retained Earnings	(77.06)	(68.38)	(53.54)	(42.68)	(57.87)	(74.62)	(84.24)	(91.26)	(98.70)	(106.79)	(124.42)	(133.68)	(187.15)	(195.69)	(196.89)	(191.91)	(191.49)	(183.07)	(172.20)	(161.71)
Total Stockholder Equity	211.08	216.00	242.94	256.55	238.95	216.62	202.78	193.11	181.01	168.04	155.73	142.72	1.33	(12.67)	(17.95)	(17.99)	(19.52)	(13.60)	(7.43)	0.08

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	62.28	64.36	58.99	118.10	113.73	98.61	88.21	92.91	84.06	87.21	84.71	86.83	81.71	81.26	71.68	74.38	67.69	66.88	58.89	67.41
Cost of Revenue	12.58	19.98	17.37	19.06	18.72	18.68	16.56	16.91	15.32	14.86	12.99	13.84	14.79	13.58	12.42	14.37	12.19	11.82	9.94	10.75
Gross Profit	49.70	44.38	41.62	99.04	95.01	79.92	71.65	76.00	68.74	72.35	71.72	72.99	66.92	67.67	59.26	60.01	55.50	55.06	48.96	56.66
Research & Development	2.80	2.78	4.14	4.76	3.70	3.30	3.33	3.57	2.92	3.01	2.84	(5.50)	3.18	8.50	6.50	5.40	5.95	5.51	5.96	4.57
Selling, General & Admin	58.31	59.78	9.32	11.84	15.28	16.28	13.11	13.40	53.52	55.40	55.13	54.35	52.57	51.93	52.28	49.95	53.48	55.79	49.57	53.07
Total Operating Expenses	61.40	62.85	57.67	77.96	72.82	67.55	63.40	64.94	57.57	48.90	58.52	46.10	56.11	64.89	62.64	58.94	62.60	64.70	58.26	53.36
Operating Income	(11.70)	(18.47)	(16.05)	21.08	22.19	12.37	8.25	11.06	11.16	23.45	13.20	26.89	10.82	2.79	(3.38)	1.07	(7.10)	(9.64)	(9.30)	3.30
Pretax Income	(11.06)	(17.78)	(15.33)	21.79	22.85	13.01	8.61	11.25	11.42	23.22	11.41	25.31	9.13	1.13	(4.93)	(0.39)	(8.37)	(10.81)	(10.43)	2.11
Tax Provision	(2.38)	(2.94)	(4.47)	6.61	6.10	3.39	1.59	3.81	3.54	5.60	2.35	(37.37)	0.59	(0.07)	0.05	0.03	0.05	0.06	0.06	(0.11)
Net Income	(8.68)	(14.84)	(10.86)	15.19	16.75	9.62	7.02	7.44	8.10	17.63	9.26	53.48	8.53	1.20	(4.98)	(0.41)	(8.43)	(10.87)	(10.49)	2.22
Basic EPS	(0.06)	(0.10)	(0.07)	0.10	0.11	0.07	0.05	0.06	0.05	0.12	0.06	0.40	0.06	0.00	(0.06)	(0.02)	(0.09)	(0.11)	(0.11)	0.01
Diluted EPS	(0.06)	(0.10)	(0.07)	0.10	0.11	0.06	0.05	0.05	0.05	0.12	0.06	0.37	0.06	0.00	(0.06)	(0.02)	(0.09)	(0.11)	(0.11)	0.01

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	3.92	(10.01)	1.88	24.96	29.33	14.42	5.30	18.78	19.62	21.81	5.98	10.26	12.79	7.78	(4.05)	(5.62)	0.96	(3.00)	(10.22)	(3.23)
Capital Expenditures	--	--	--	--	--	--	--	--	0.00	0.37	5.00	0.43	0.63	0.30	0.63	--	0.35	0.38	0.12	--
Free Cash Flow*	--	--	--	--	--	--	--	--	19.62	21.45	0.98	9.83	12.16	7.48	(4.68)	--	0.61	(3.38)	(10.34)	--
Investing Cash Flow	(0.19)	(0.63)	(5.64)	(0.33)	(5.26)	(0.89)	(0.41)	(2.77)	0.11	(0.90)	(6.02)	(0.48)	(0.65)	(0.35)	(0.68)	(1.71)	(0.37)	(0.43)	(0.15)	(0.31)
Financing Cash Flow	(18.77)	(13.28)	(2.58)	(0.58)	(0.86)	(1.09)	(2.88)	(0.40)	0.03	(0.36)	(33.47)	(8.94)	0.37	0.00	-0.00	0.07	0.13	0.26	(1.04)	0.02

← Scroll for more columns →

* Derived from reported values